Loading
NP
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) Stock: price and insider trades · Canada
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.): what insiders have been doing
Every trade that managers of Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) disclose to SEDI is tracked on this page. Nothing new has been filed by managers of Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) in twelve months, the latest record being from 2 July 2020.
Our records for Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) go back to 2016, with 55 purchases and 3 sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
102
Thresholds
n/a
Buy Volume
€74,774
55 ops. · all time
Sell Volume
n/a
3 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 2 July 2020
Declarations102 total
7,000 shares@ CA$0.7913.1% of flowCommon SharesTSXSEDI:3569729
Canonical exit: 28 Sept 2020 (T+90)
1,500 shares@ CA$0.801.5% of flowCommon SharesTSXSEDI:3564469
Canonical exit: 14 Sept 2020 (T+90)
2,500 shares@ CA$0.802.4% of flowCommon SharesTSXSEDI:3564468
Canonical exit: 13 Sept 2020 (T+90)
2,500 shares@ CA$0.792.4% of flowCommon SharesTSXSEDI:3563545
Canonical exit: 10 Sept 2020 (T+90)
2,500 shares@ CA$0.802.4% of flowCommon SharesTSXSEDI:3562582
Canonical exit: 9 Sept 2020 (T+90)
8,000 shares@ CA$0.78814.9% of flowCommon SharesTSXSEDI:3561610
Canonical exit: 3 Sept 2020 (T+90)
2,000 shares@ CA$0.562.6% of flowCommon SharesTSXSEDI:3561809
Canonical exit: 11 Jun 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3561744
Canonical exit: 7 Sept 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3561187
Canonical exit: 6 Sept 2020 (T+90)
2,500 shares@ CA$0.7822.4% of flowCommon SharesTSXSEDI:3560777
Canonical exit: 3 Sept 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3559597
Canonical exit: 2 Sept 2020 (T+90)
2,500 shares@ CA$0.7482.3% of flowCommon SharesTSXSEDI:3558852
Canonical exit: 1 Sept 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3558495
Canonical exit: 31 Aug 2020 (T+90)
2,500 shares@ CA$0.7822.4% of flowCommon SharesTSXSEDI:3557603
Canonical exit: 30 Aug 2020 (T+90)
2,500 shares@ CA$0.8242.5% of flowCommon SharesTSXSEDI:3555718
Canonical exit: 26 Aug 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3555243
Canonical exit: 24 Aug 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3555244
Canonical exit: 25 Aug 2020 (T+90)
2,500 shares@ CA$0.792.4% of flowCommon SharesTSXSEDI:3554396
Canonical exit: 23 Aug 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3553780
Canonical exit: 20 Aug 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3552925
Canonical exit: 19 Aug 2020 (T+90)
2,500 shares@ CA$0.802.5% of flowCommon SharesTSXSEDI:3552536
Canonical exit: 18 Aug 2020 (T+90)
2,500 shares@ CA$0.702.2% of flowCommon SharesTSXSEDI:3552133
Canonical exit: 17 Aug 2020 (T+90)
2,500 shares@ CA$0.672.1% of flowCommon SharesTSXSEDI:3551456
Canonical exit: 13 Aug 2020 (T+90)
10,000 shares@ CA$0.7016.7% of flowCommon SharesTSXSEDI:3551434
Canonical exit: 12 Aug 2020 (T+90)
5,000 shares@ CA$0.738.7% of flowCommon SharesTSXSEDI:3551441
Canonical exit: 12 Aug 2020 (T+90)
25 of 102 declarations
About Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.)
Nuvo Pharmaceuticals Inc. is a Canadian pharmaceutical company focused on the development and commercialization of therapeutic products. Formerly known as Nuvo Research Inc., it is listed on the Toronto Stock Exchange.
